16 October

Staff Spotlight: Tim Reed

12 October

Giving Snakebite Victims a Voice

25 September

HAI’s Research into Access to Sexual and Reproductive Health Commodities Now in Full Swing

14 August

Staff Spotlight: Gemma Buckland-Merrett

16 May

Staff Spotlight: Mieke Bakx

4 May

Small country, big thinkers: Why it’s only natural for the Netherlands to take on a pioneering role in snakebite advocacy

4 April

Staff Spotlight: Molly Lepeska

15 February

European Commission Appoints Health Action International to HTA Network Stakeholder Pool

13 December

Health Action International Launches Study to Examine Access to Sexual and Reproductive Health Commodities in Kenya, Uganda and Zambia

1 December

Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit

27 July

Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines

18 May

Top Experts to Discuss Global Initiatives to Reduce Snakebite Death & Disability at WHA69 Side Event

12 May

ACCISS Infographics

23 February

Farewell to Access to Medicines Pioneer, Andrew Herxheimer

6 February

Insulin Still Unattainable for Many Living with Diabetes Worldwide: ACCISS Study Review in The Lancet D&E

11 December

HAI/WHO Pharmaceutical Promotion Manual Still Key to Combating Promotion around the World

28 September

HAI Holds Workshops on EU Medicines Policy & Access to Medicines in Eastern Europe

9 June

HAI urges MEPs to support key amendments to TTIP resolution

4 February

The EU-US Trade Deal Could Leave Europeans Sick

16 January

HAI Launches Innovative Global Study to Improve Access to Insulin

9 December

More work needed on new EMA conflicts of interest policy

15 October

EMA policy on clinical data publication a step ahead, but falls short of true potential

18 September

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry

16 September

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

15 July

School's IN for summer: HAI staff and interns inspired by Utrecht University's course on pharmaceutical policy analysis

23 June

Setting precedents: EMA must get clinical trial data policy right to truly act in public interest

11 June

HAI Europe calls on EMA's Management Board to stand for data transparency

10 April

Tamiflu review shows desperate need for full clinical trials data transparency

24 February

A new (and improved) model to regulate pharmaceutical promotion

12 February

Enhancing accountability in the medicines market: The Medicines Transparency Alliance